Skip to main content

Hybrid Operating Room Market Trends and Industry Analysis Report

The global hybrid operating room market is segmented by component, application, end user and region. Based on component, the hybrid operating rooms market is segmented into intraoperative diagnostic imaging systems, operating room fixtures, surgical instruments, audio-visual display systems and tools, and other components. The intraoperative diagnostic imaging systems segment accounted the largest share of the hybrid operating room market in 2017; owing to factors such as increasing installation of hybrid ORs across major countries, ongoing integration and automation of OR workflows, and continuous technological advancements in the field of diagnostic imaging.

The global hybrid operating room market is projected to reach USD 1.17 billion by 2022 at a CAGR of 12.5% during forecast period. The major factors driving the growth of the hybrid operating room market include the increasing adoption of minimally invasive surgical procedures and ongoing technological advancements.

As of 2016, Koninklijke Philips N.V. (Netherlands) held the leading position in the global hybrid operating room market. Philips Healthcare is one of the leading manufacturers of intraoperative imaging systems for hybrid operating rooms and offers integrated image-guided therapy solutions for hybrid operating rooms. The company focuses on increasing its product offerings as well as expanding the application for image-guided systems. In order to strengthen its current position and to gain a larger share in the hybrid operating rooms market, the company aggressively focuses on inorganic and organic business growth strategies such as partnerships, product launches, approvals, and product deployment.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=264471209

Also, Toshiba (Japan), Siemens (Germany), General Electric Company (US), and Stryker Corporation (US) were few other key players operating in the market.

Emerging markets (such as India, China, Japan, New Zealand, Indonesia, and South Korea) are expected to offer significant growth opportunities due to the rapid growth in the healthcare expenditure in emerging APAC countries, which will support the adoption of advanced surgical & diagnostic technologies in their respective healthcare systems, presence of large patient population for chronic diseases coupled with the rapidly growing geriatric population, rising awareness of advanced medical imaging technologies, ongoing government initiatives to modernize & expand healthcare infrastructure across emerging Asian countries, continuous reduction in the cost of products associated with hybrid OR settings and growing trend of medical tourism across RoAPAC.

Cardiovascular Applications
The cardiovascular applications of hybrid operating room settings include integrated usage of advanced diagnostic as well as surgical devices to assist in cardiovascular surgeries to treat congenital heart diseases, heart valve diseases, coronary artery diseases, and arrhythmias, among others. This segment accounted for the largest share due to the increasing preference of cardiac surgeons for hybrid OR settings during target surgical procedures, growing market trend towards the adoption of endovascular procedures during cardiovascular surgeries, and increased patient emphasis on effective disease management strategies.

Know more: https://www.marketsandmarkets.com/Market-Reports/hybrid-operating-room-market-264471209.html

Comments

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...